While this study is focused on documenting the mechanism of ginsenoside Rb1–mediated erythroid rescue in DBA models, these data suggest that combining ginsenoside Rb1 (or other modulators of miR-208 expression) may have additional therapeutic benefit to other therapies that may suppress NLK expression/activity by other mechanisms. The gene discussed is NLK; the disease is Diamond-Blackfan anemia.